EVEREST MEDICINES
Live / Applied — Revived — awaiting further action (as of 26 Feb 2026)
What this means for you
Not registered yet, but its 22 Feb 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98416690
- Mark type
- Stylized text
- Filed
- 22 Feb 2024
- Published for opposition
- 17 Dec 2024
- Attorney of record
- Khanh T. Glatzel
Goods and services
- Class 001 — Chemicals: Active chemical ingredients for use in the manufacture of anti-cancer drugs; chemical additives for use in the manufacture of medicines; active chemical substances for use in the production of drugs for treating and preventing nephropathy, bacterial infection, cancer, gastrointestinal inflammation.
Owner
- Everest Medicines (Singapore) Pte. Ltd., Singapore, SG
- Everest Medicines (Singapore) Pte. Ltd., Singapore, SG
Prosecution history
- 26 Feb 2026 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 26 Feb 2026 — NOTICE OF REVIVAL - E-MAILED
- 26 Feb 2026 — PETITION TO REVIVE-GRANTED
- 26 Feb 2026 — TEAS PETITION TO REVIVE RECEIVED
- 24 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Feb 2026 — CORRECTED NOA E-MAILED
- 24 Feb 2026 — SOU EXTENSION 1 GRANTED
- 07 Aug 2025 — SOU EXTENSION 1 FILED
- 24 Feb 2026 — DIVISIONAL PROCESSING COMPLETE
- 08 Aug 2025 — DIVISIONAL REQUEST RECEIVED
- 08 Aug 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 13 Feb 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Aug 2025 — TEAS STATEMENT OF USE RECEIVED
- 08 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT